Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

PROCEPT BioRobotics (PRCT) Accumulated Depreciation & Amortization (2020 - 2025)

PROCEPT BioRobotics has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $6.4 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $6.4 million for Q4 2025, up 22.09% from a year ago — trailing twelve months through Dec 2025 was $6.4 million (up 22.09% YoY), and the annual figure for FY2025 was $6.4 million, up 22.09%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $6.4 million at PROCEPT BioRobotics, up from $4.7 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for PRCT hit a ceiling of $6.4 million in Q4 2025 and a floor of $758000.0 in Q1 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $2.5 million (2023), compared with a mean of $2.7 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: fell 17.16% in 2022 and later soared 70.94% in 2024.
  • PROCEPT BioRobotics' Accumulated Depreciation & Amortization stood at $3.3 million in 2021, then dropped by 14.53% to $2.8 million in 2022, then surged by 34.0% to $3.8 million in 2023, then skyrocketed by 37.48% to $5.2 million in 2024, then increased by 22.09% to $6.4 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $6.4 million (Q4 2025), $4.7 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.